TNF and Scheie syndrome: Adalimumab, a human monoclonal antibody that inhibits TNF-α, has been proven effective and safe by Polgreen et al. (2017) for patients with MPS I and II in a 32-week, randomized, double blind, placebo-controlled, crossover study (NCT02437253; NCT03153319).